BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 3

Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China

Jiao, Fuyong; Pan, Yan; Du, Zhongdong; Deng, Fangming; Yang, Xiaodong; Wang, Hong; Shen, Jie; Xiang, Wei; Mu, Zhilong; Gao, Chunyan; Bai, Jinmei.
BMC pediatr. (Online); 24 (1), 2024
Kawasaki disease (KD) is a pyretic ailment predominantly observed in children aged below 5 years. There is currently a dearth of precise markers for timely identification of incomplete Kawasaki disease (IKD). It is imperative to develop updated, comprehensive, and evidence-based guidelines to effectively...
Síndrome de Linfonodos Mucocutâneos/diagnóstico, Síndrome de Linfonodos Mucocutâneos/tratamento farmacológico, Imunoglobulinas/uso terapêutico, China, Metilprednisolona/uso terapêutico, Administração Intravenosa
Texto completo

Diagnosis and management of heparin-induced thrombocytopenia: third edition

Arachchillage, Deepa J; Thachil, Jecko; Anderson, Julia A. M; Baker, Peter; Poles, Anthony; Kitchen, Steve; Laffan, Mike.
Br. j. haematol; 204 (2), 2024
This guideline updates and widens the scope of the previ-ous British Society for Haematology (BSH) Clinical guide-lines for Diagnosis and Management of Heparin-Induced Thrombocytopenia: Second Edition1 to include functional assays in the diagnosis of heparin-induced thrombocy...
Heparina/uso terapêutico, Trombocitopenia/tratamento farmacológico, Trombocitopenia/diagnóstico, Plaquetas/efeitos dos fármacos, Imunoglobulinas/análise, Fator Plaquetário 4/análise
Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Nirsevimab, Season 1

MMWR recomm. rep; 72 (34), 2023
A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) review of the evidence for benefits and harms of the long-acting monoclonal antibody nirsevimab, (Beyfortus, Sanofi and AstraZeneca) for prevention of respiratory syncytial virus (RSV)-associated lower respiratory tract infecti...
Anticorpos Monoclonais/uso terapêutico, Vírus Sinciciais Respiratórios, Imunoglobulinas
Texto completo